Announcing A New IVIG for PI

ASCENIV® [Immune Globulin Intravenous (Human), 10% Liquid]

ASCENIV™, formerly referred to as RI-002, is NOW FDA APPROVED for primary humoral immunodeficiency (PI) in adults and adolescents (12 to 17 years of age).

ASCENIV is a plasma-derived, polyclonal, immune globulin intravenous (human) 10% liquid.